What does Apotheek Omnia do?

Apotheek Omnia is a pharmacy in Koksijde. Public Limited, started on 21 January 1952, 1 establishment.

What is the address of Apotheek Omnia?

The registered office of Apotheek Omnia is located at Koninklijke Baan(Kok) 154, 8670 Koksijde.

Is Apotheek Omnia still active?

Yes. According to the CBE (30 October 2026) Apotheek Omnia is active, legal situation “Normale toestand”, started on 21 January 1952.

Is Apotheek Omnia registered on Peppol?

Yes, Apotheek Omnia is registered on the Peppol network with ID 0208:0405813851.

What is the enterprise number of Apotheek Omnia?

The enterprise number of Apotheek Omnia is BE0405813851.

When was Apotheek Omnia founded?

Apotheek Omnia was founded on 21 January 1952.

Who are the directors of Apotheek Omnia?

According to the 2025 annual accounts, the directors of Apotheek Omnia are: Lindammer CommV, Marceau DECRU, DEMARAX BV BV, O.P.S. BV BV.

Is Apotheek Omnia a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 January 1952; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did Apotheek Omnia make in 2025?

Apotheek Omnia posted a profit after taxes of € 56,058 in financial year 2025.

What is the revenue of Apotheek Omnia?

As a small company, Apotheek Omnia is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 270,247.

How much does an employee at Apotheek Omnia earn?

The average wage cost per full-time employee at Apotheek Omnia was € 54,100 in 2025: staff costs of € 162,175 for 3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek Omnia have?

According to the 2025 annual accounts, Apotheek Omnia has 3 full-time equivalents (FTE).

Apotheek Omnia (Public Limited) - Koksijde - BE0405813851

Dossier Apotheek Omnia, printed on 30 October 2026 from databakkes.be/en/0405813851/apotheek-omnia. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 4.1 to 3.

Financials

Financial year 2025

Apotheek Omnia from Koksijde, company number BE0405813851, closed financial year 2025 with a result of € 56,058 after tax. For that financial year Apotheek Omnia recorded a gross margin of € 270,247 and equity of € 859,867. Compared with financial year 2024, the result moved from € 95,836 to € 56,058. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 3, 2026.

What it is worth Growing

€ 859,867

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 56,058

▼ 42% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 115,165

▲ 35% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 797,893.

People and assets in 2025

Full-time equivalents

▼ 0.4 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 162,175

▼ 8% vs 2024

€ 54,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 24,167

▼ 29% vs 2024

€ 10,000 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 230,627

▲ 70% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 33,439

▼ 48% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 416,802 Gross margin 2022: € 416,802 First fiscal year in the series	€ 290,087 Gross margin 2023: € 290,087 ▼ 30% vs 2022 (€ 416,802) Unfavourable step	€ 346,901 Gross margin 2024: € 346,901 ▲ 20% vs 2023 (€ 290,087) Favourable step	€ 270,247 Gross margin 2025: € 270,247 ▼ 22% vs 2024 (€ 346,901) Unfavourable step	▼ 22%
Profit after taxes	€ 148,821 Profit after taxes 2022: € 148,821 First fiscal year in the series	€ 45,353 Profit after taxes 2023: € 45,353 ▼ 70% vs 2022 (€ 148,821) Unfavourable step	€ 95,836 Profit after taxes 2024: € 95,836 ▲ 111% vs 2023 (€ 45,353) Favourable step	€ 56,058 Profit after taxes 2025: € 56,058 ▼ 42% vs 2024 (€ 95,836) Unfavourable step	▼ 42%
Equity	€ 662,620 Equity 2022: € 662,620 First fiscal year in the series	€ 707,973 Equity 2023: € 707,973 ▲ 7% vs 2022 (€ 662,620) Favourable step	€ 803,809 Equity 2024: € 803,809 ▲ 14% vs 2023 (€ 707,973) Favourable step	€ 859,867 Equity 2025: € 859,867 ▲ 7% vs 2024 (€ 803,809) Favourable step	▲ 7%
Total debts	€ 751,559 Total debts 2022: € 751,559 First fiscal year in the series	€ 752,933 Total debts 2023: € 752,933 Unchanged (€ 751,559) Unfavourable step	€ 696,601 Total debts 2024: € 696,601 ▼ 7% vs 2023 (€ 752,933) Favourable step	€ 416,257 Total debts 2025: € 416,257 ▼ 40% vs 2024 (€ 696,601) Favourable step	▼ 40%
Cash	€ 37,096 Cash 2022: € 37,096 First fiscal year in the series	€ 90,676 Cash 2023: € 90,676 ▲ 144% vs 2022 (€ 37,096) Favourable step	€ 85,353 Cash 2024: € 85,353 ▼ 6% vs 2023 (€ 90,676) Unfavourable step	€ 115,165 Cash 2025: € 115,165 ▲ 35% vs 2024 (€ 85,353) Favourable step	▲ 35%
Land & buildings	€ 420,767 Land & buildings 2022: € 420,767 First fiscal year in the series	€ 397,993 Land & buildings 2023: € 397,993 ▼ 5% vs 2022 (€ 420,767) Unchanged	€ 394,219 Land & buildings 2024: € 394,219 ▼ 1% vs 2023 (€ 397,993) Unchanged	€ 371,445 Land & buildings 2025: € 371,445 ▼ 6% vs 2024 (€ 394,219) Unchanged	▼ 6%
Retained profit	€ 600,646 Retained profit 2022: € 600,646 First fiscal year in the series	€ 646,000 Retained profit 2023: € 646,000 ▲ 8% vs 2022 (€ 600,646) Favourable step	€ 741,836 Retained profit 2024: € 741,836 ▲ 15% vs 2023 (€ 646,000) Favourable step	€ 797,893 Retained profit 2025: € 797,893 ▲ 8% vs 2024 (€ 741,836) Favourable step	▲ 8%
Bank debt	€ 60,762 Bank debt 2022: € 60,762 First fiscal year in the series	€ 50,704 Bank debt 2023: € 50,704 ▼ 17% vs 2022 (€ 60,762) Favourable step	€ 34,167 Bank debt 2024: € 34,167 ▼ 33% vs 2023 (€ 50,704) Favourable step	€ 24,167 Bank debt 2025: € 24,167 ▼ 29% vs 2024 (€ 34,167) Favourable step	▼ 29%
Balance sheet total	€ 1,414,179 Balance sheet total 2022: € 1,414,179 First fiscal year in the series	€ 1,460,906 Balance sheet total 2023: € 1,460,906 ▲ 3% vs 2022 (€ 1,414,179) Unchanged	€ 1,500,410 Balance sheet total 2024: € 1,500,410 ▲ 3% vs 2023 (€ 1,460,906) Unchanged	€ 1,276,123 Balance sheet total 2025: € 1,276,123 ▼ 15% vs 2024 (€ 1,500,410) Unchanged	▼ 15%
Employees (FTE)	3.3 Employees (FTE) 2022: 3.3 First fiscal year in the series	4.1 Employees (FTE) 2023: 4.1 ▲ 0.8 vs 2022 (3.3) Unchanged	3.4 Employees (FTE) 2024: 3.4 ▼ 0.7 vs 2023 (4.1) Unchanged	3 Employees (FTE) 2025: 3 ▼ 0.4 vs 2024 (3.4) Unchanged	▼ 0.4

Key figures of Apotheek Omnia, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 March 2027.

What happened to Apotheek Omnia?

What happened at Apotheek Omnia in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 3, 2026 New annual accounts for financial year 2025: profit of € 56,058 (▼ 42% vs 2024). Source: NBB ↗
2025 Lindammer CommV became a director. NBB
Jan 21, 1952 Start of the company according to the CBE. KBO
Jan 1, 1952 New establishment in Koksijde. KBO

In short

From € 148,821 profit in 2022 to € 56,058 profit in 2025.

Paid € 133,106 in corporate taxes since 2022.

Best year ever: 2022, with € 148,821 profit.

On average € 90,100 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

O.P.S. 99%

The stake of O.P.S. comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Omnia

Behind Apotheek Omnia are Lindammer CommV, Marceau DECRU, DEMARAX BV BV and O.P.S. BV BV. The shares are held by O.P.S. (99%).

Directors

According to the 2025 annual accounts

Lindammer CommV

Director · represented by Marceau DECRU

Also active at: ALMAPHARMA, ODEPHARMA, APOTHEEK SINT-IDESBALD

since 2025

Marceau DECRU

Director

Also active at: ALMAPHARMA, ODEPHARMA, ROMAPHARM, APOTHEEK SINT-IDESBALD, DEMARAX

DEMARAX BV BV

Director · represented by Pascale HOUVENAGHEL

Also active at: ROMAPHARM

O.P.S. BV BV

Managing director · represented by Geert DECRU

Also active at: OLIVINI, ROMAPHARM

Shareholders

O.P.S.

99%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Koninklijke Baan(Kok) 154

8670 Koksijde

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0405.813.851

VAT number

BE 0405.813.851

Registered office

Koninklijke Baan(Kok) 154, 8670 Koksijde

Names & denominations

Apotheek Omnia

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

21 January 1952

Peppol

Active · Active since 15 Aug 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Omnia

Warning lights

Financials

What happened to Apotheek Omnia?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions